SOST and osteosclerosis: This study identified two kinds of new mutations in LRP5 for the first time, of which the mutation in exon 3 may cause amino acid changes in the binding site of LRP5 with SOST, an antagonist protein in Wnt pathway, resulting in more severe phenotype of osteosclerosis.